Global Eye Health Supplements Market

Eye Health Supplements Market Size, Share, Growth Analysis, By Ingredient Type (Lutein & Zeaxanthin, Antioxidants), By Indication (Age-related Macular Degeneration (AMD), Cataract), By Formulation (Tablets, Capsules), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35I2201 | Region: Global | Published Date: December, 2025
Pages: 219 |Tables: 125 |Figures: 77

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Eye Health Supplements Market size was valued at USD 2.67 Billion in 2024 and is poised to grow from USD 2.85 Billion in 2025 to USD 4.79 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026–2033).

    To preserve their market position, key corporations are pursuing various business strategies such as mergers, collaborations, & new product releases. For example, in 2021 the Japanese business Nippon Flour Mills announced the release of eye and brain flavonoid supplements containing lutein, Ginkgo Biloba, terpene lactone, & zeaxanthin. 'Santen Pharmaceutical (Japan)', 'Rohto Pharmaceutical (Japan) ', 'Dompé Farmaceutici (Italy) ', 'Vianex S.A. (Greece) ', 'Abbott Laboratories (USA) ', 'Bausch + Lomb (USA) ', 'Alcon (Switzerland) ', 'Pfizer Inc. (USA) ', 'Novartis AG (Switzerland) ', 'Théa Pharma (France) ', 'Similasan AG (Switzerland) ', 'Jamieson Wellness (Canada) ', 'Nature's Way (USA) ', 'NOW Foods (USA) ', 'Nature's Bounty (USA) ', 'GNC Holdings (USA) ', 'Herbalife Nutrition (USA) ', 'Amway (USA) ', 'Pharma Nord (Denmark) ', 'Solgar (USA)'

    The rising prevalence of eye-related disorders, such as age-related macular degeneration (AMD), cataracts, and dry eye syndrome, is driving the demand for eye health supplements. As the aging population increases globally, the incidence of these disorders is expected to rise, creating a growing market for supplements that support eye health.

    Increasing Consumer Awareness and Proactive Approach to Eye Health: There is a growing awareness among consumers about the importance of maintaining good eye health and preventing age-related eye conditions. Consumers are taking a proactive approach to eye health and seeking out eye health supplements as a part of their overall wellness regimen.

    North America held the biggest market revenue share of 35.6% in 2023. The rising prevalence of chronic eye diseases, particularly AMD, diabetic retinopathy, glaucoma, and dehydrated eye syndrome, as well as increased awareness and availability of commercialized eye health supplements, are a few of the key factors contributing to North America's largest revenue share. Furthermore, a surge in new products for eye care supplements in the region is a major factor driving market expansion in North America.  

    Related Reports

    Eye Health Ingredients Market
    Buy Now GET FREE SAMPLE
    Dietary Supplements Market
    Buy Now GET FREE SAMPLE
    Liver Health Supplements Market
    Buy Now GET FREE SAMPLE
    Vitamin Supplements Market
    Buy Now GET FREE SAMPLE
    Immune Health Supplements Market
    Buy Now GET FREE SAMPLE
    Brain Health Supplements Market
    Buy Now GET FREE SAMPLE
    Ophthalmic Disease Therapeutics Market
    Buy Now GET FREE SAMPLE
    Ophthalmic Drugs Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Eye Health Supplements Market

    Report ID: SQMIG35I2201

    $5,300
    BUY NOW